26 June 2020 : Original article
Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?
Samantha L. Terranella1ABDEF, Jennifer Poirier1ACDE, Edie Y. Chan1ADE, Martin Hertl1ADE, Oyedolamu K. Olaitan1ABCDEF*DOI: 10.12659/AOT.924061
Ann Transplant 2020; 25:e924061
Table 2 Baseline recipient, donor, and operative characteristics by HbA1c level.
HbA1c ≤7.7% (135 patients) | HbA1c >7.7% (30 patients) | p-Value | |
---|---|---|---|
Recipient age (years) | 57.9 (10.2) | 56.1 (9.6) | 0.40 |
BMI (kg/m) | 29 (5.2) | 30.5 (5.2) | 0.13 |
Time on dialysis (months) | 47 (39.5) | 35 (29.0) | 0.25 |
Length of stay (days) | 9.3 (14) []6 | 7.2 (2.7) []6 | 0.80 |
Cold ischemia time (hours) | 22 (9.8) | 20 (10.6) | 0.40 |
Anastomotic time (minutes) | 49 (15.2) | 47 (11.5) | 0.70 |
PRA | 11.8 (23.8) | 17.6 (33.4) | 0.90 |
Follow-up (months) | 39.2 (14.7) | 42 (16.4) | 0.21 |
Donor age (years) | 42 (17) | 44 (15) | 0.50 |
Re-transplant | 0.50 | ||
Yes | 13 (10%) | 3 (10%) | |
No | 122 (90%) | 27 (90%) | |
Gender | 0.80 | ||
Female | 49 (36%) | 9 (30%) | |
Male | 86 (64%) | 21 (70%) | |
Race | 0.70 | ||
Black | 52 (39%) | 11 (36.7%) | |
Hispanic | 38 (28%) | 11 (36.7%) | |
White | 34 (25%) | 7 (23.3%) | |
Other | 11 (8%) | 1 (3.3%) | |
Type of diabetes | 0.05 | ||
Type I | 4 (3%) | 6 (20%) | |
Type II | 111 (82%) | 22 (73.3%) | |
Unclassified | 20 (15%) | 2 (6.7%) | |
Diabetic medications | 0.40 | ||
Insulin | 92 (68%) | 23 (77%) | |
OHA | 21 (15%) | 4 (13%) | |
Both | 18 (13%) | 3 (10%) | |
Type of graft | 0.26 | ||
SCD | 93 (69%) | 16 (53%) | |
ECD | 27 (20%) | 9 (30%) | |
DCD | 15 (11%) | 5 (17%) | |
Donor type | 0.18 | ||
Deceased donors | 70 (52%) | 17 (57%) | |
Living donors | 65 (48%) | 13 (43%) | |
Data presented as mean (standard deviation) [median] or count (percentage). PRA – Panel Reactive Antibody; OHA – Oral Hypoglycemic Agent; SCD – Standard Criteria Donor; ECD – Extended Criteria Donor; DCD – Donation after Cardiac Death. |